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Abstract
Background: Urinary incontinence (UI) is a prevalent symptom in middle-aged women, but data
on incidence is limited and rarely reported. In order to analyze incidence, remission, or
development patterns of severity and types of UI, we have established a 15-year prospective cohort
(1997–2012).
Methods: The Cohort is based on the national collection of health data gathered from county
studies (CONOR). Hordaland Health Study (HUSK) is one of them from Hordaland County. Each
of the county studies may have local sub-studies and our Cohort is one of them. The Cohort
included women aged 40–45 in order to have a broad approach to women's health including UI and
other lower urinary tract symptoms (LUTS). A onefifth random sampling from HUSK was used to
create the Cohort in 1997–1999. For the necessary sample size a preliminary power calculation,
based on a 70% response rate at inclusion and 5% annual attrition rates was used. The Cohort is
planned to collect data through questionnaires every second year for the 15-year period from
1997–2012.
Discussion: The Cohort represents a relatively large random sample (N = 2,230) of about 15% of
the total population of women born between 1953–57 in the county of Hordaland. Our data shows
that the cohort population is very similar to the source population. The baseline demographic,
social and medical characteristics of the Cohort are compared with the rest of women in HUSK
(N = 7,746) and there were no significant differences between them except for the level of
education (P = 0.001) and yearly income (P = 0.018), which were higher in the Cohort population.
Urological characteristics of participants from the Cohort (N = 1,920) were also compared with
the other participants (N = 3,400). There were no significant statistical differences except for
somewhat more urinary continence (P = 0.04), more stress incontinence (P = 0.048) and smaller
amount of leakage (P = 0.015) in the Cohort. In conclusion, the Cohort ispopulation-based, with
little selection bias, and thus is a rather unique study forinvestigating UI and LUTS in comparison
with many other projects with similar purposes.
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Urinary symptoms are an integral part of the transition
from the premenopausal to the postmenopausal state.
Decrease in natural hormones and other ageing processes
in perimenopausal women induce changes in the urinary
tract and vagina, and women become more susceptible to
the development of bladder storage symptoms like uri-
nary frequency, urgency and stress incontinence. Beside
urinary incontinence (UI), pelvic organ prolapse may
occur. UI is a prevalent problem in middle-aged women,
but data on incidence are limited and rarely reported [1-
3]. The prevalence of UI increases with age. A recent major
study found a gradual increase in the prevalence of UI
throughout adulthood until the fifth decade, it after
which it stabilized and even registered slight decrease up
to age 70; after that, it started to rise again [4].
Epidemiological and clinical studies conducted in various
populations have revealed risk factors and contributing
variables for UI and other lower urinary tract symptoms
(LUTS). Factors such as smoking, menopause, restricted
mobility, chronic cough, chronic straining due to consti-
pation and uro-genital surgery have not been as rigorously
studied as age, parity and obesity. Data on risk factors for
the incidence of UI, remission and natural history of LUTS
is limited and has been derived mainly from cross-sec-
tional studies. This limits generalisation and restricts
interpretation of causality. To show the temporal ordering
between risk factors and onset of UI, a prospective or lon-
gitudinal design is necessary [2,3]. It has proven difficult
to show predictors for incident UI except for pregnancy
and delivery and some specific, but rare conditions like
stroke and other neurological diseases. It has been docu-
mented that remission can take place, but its predictors
are not well understood. It may be related to natural
recovery or to medical care, but variation caused by unre-
liable measurements cannot be excluded [2].
Most previous studies on incidence have been small [5,6],
have had few follow-ups or have a limited description of
the type and severity of UI [5,7]. UI is part of a broader
picture of urinary symptoms in middle-aged women.
Both overactive bladder and other LUTS are prevalent [8],
and several other health issues may be relevant and
related in this age range of age. To answer some of the cur-
rent issues we started a prospective cohort in 1997, The
Hordaland women's cohort. This Cohort included women
aged 40–45 years with a planned 15-year follow-up, to
have a broad approach to women's health including UI
and other LUTS. In 2007 the Cohort reached a 10-year fol-
low up, and the present paper focuses on the design of the
study, inclusion and recruitment, response rates and loss
to follow-up, together with baseline characteristics of the
cohort population.
Methods
The Hordaland Women's Cohort is based on the publicly
managed system for epidemiological research in Norway.
The first level of this system consists of CONOR, the
Cohort of Norway, which is a national collection of health
data gathered from the second level i.e. the county studies.
Each of the county studies may in turn have local sub-
studies for specific purposes, diseases or populations and
this is the third level.
CONOR
Norway has particular advantages for epidemiological
research because it is a survey-able and well-organized lit-
tle country, where each individual has a unique ID
number. This is the background for the foundation of
CONOR [9]. CONOR is both the name of a collection of
health data and blood samples, and of the collaboration
between the Norwegian Institute of Public Health and the
universities in Oslo, Bergen, Tromsø and Trondheim. In
CONOR, regional data from 10 different epidemiological
studies have been merged into a national database that is
more representative of the Norwegian population than
each of the individual sites. The first data was collected in
1994 and the last will be included in 2008. Altogether
nearly 200000 people will be included.
The database consists of information obtained from ques-
tionnaires, a simple physical examination, analyses of
blood samples, and frozen stored blood and/or DNA. The
CONOR questions cover the following main topics: self-
reported health and diseases such as diabetes, asthma,
coronary heart disease, stroke and mental distress, musc-
uloskeletal pains, family history of disease, risk factors
and lifestyle, surrounding environment, social network
and social support, education, work and housing, some
occupations, use of medications and reproductive history
(women). Most of the studies consist of a central core and
several supplementary projects. The main purpose of
CONOR is to study the aetiology of rare diseases by test-
ing environmental, inheritable, cultural and social factors
to describe the dispersion of diseases and risk factors by
time, place and socio-demographic factors. One of the
county health surveys was the Hordaland Health Study
(HUSK) [10].
HUSK
HUSK (1997–1999) was a joint epidemiological research
project carried out by the National Health Screening Serv-
ice in collaboration with the University of Bergen. The
study population included all individuals in Hordaland
County born between 1953–57 (29,335), and aged 40–44
at the time of the data collection.
A questionnaire was mailed to the invited people, with an
invitation to a health check-up. The completed question-Page 2 of 8
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participant signed a written consent form. A total of
18,581 (8,598 men and 9,983 women) answered the
questionnaire and came to clinical examinations, yielding
a participation rate of 63% (57% for men and 70% for
women). Baseline measurements included height, weight,
waist and hip circumference, blood pressure, heart rate,
non-fasting analyses of serum total cholesterol, HDL cho-
lesterol, triglycerides, creatinine and glucose. Self-admin-
istered questionnaires including open-ended questions
on occupation and industrial affiliation as well as use of
medicinal and dietary supplements provided information
on various health behaviours. One of the accessory ques-
tionnaires had a comprehensive section on LUTS. This
questionnaire was randomly given to 65% of women at
screening stations, to be filled in at home and sent back.
HUSK was then used as the basis for creating a prospective
cohort of middle-aged women in Hordaland.
The Hordaland Women's Cohort Study
Random sampling
The HUSK female population aged 40–45 was the source
population for the Cohort. A random sampling of one-
fifth of them was used. Those who came to the screening
station received information about the Cohort. They even-
tually agreed to take part in the study by signing an
informed consent form. For random sampling, the last
digit of the personal ID number was used. For the neces-
sary sample size a preliminary power calculation, based
on a 70% response rate at inclusion and 5% annual attri-
tion rates was used. With this calculation, at least 2,150
women should be asked to join at the baseline if at least
900 women should remain in the cohort after 10 years.
Questionnaire and variables
All information collected for HUSK participants formed
the first data point (baseline dataset) for the Cohort mem-
bers. Since then, postal questionnaires have been sent
every second year to the Cohort members. The question-
naires have been almost identical each time and have four
major parts. Table 1 shows the topics covered in the first 6
waves of the study.
The first part (health, lifestyle and physical activity) covers
variables like: age, self-rated general health, visits to doc-
tor/hospital, physical activity, weight, pelvic floor exer-
cises and smoking. This part also contains questions
about complementary treatments such as acupuncture
and homeopathy. When the questionnaire is returned, the
International Classification of Primary Care (ICPC) [11]
was used to code the reason for visiting a doctor or hospi-
tal.
The second part (contraception and menopause) asks
about menstruation pattern and possible pre- and post-
menopausal symptoms, the severity of the symptoms, use
of hormones, contraception methods and a specific ques-
tion about what kind of doctor (GP or specialist) pre-
scribes contraceptives or intra-uterine devices (IUD).
The third part of the questionnaire (urinary conditions)
contains two major sections. The first section is for all par-
ticipants and contains nine questions about frequency of
voiding each day, nocturia, bladder emptying, strength of
urination, and experiences about leakage of urine in dif-
ferent situations. By combining the two questions about
frequency and amount of leakage, the incontinence sever-
ity index (ISI, Sandvik index) [12] can be calculated. ISI is
based on information about frequency (four levels) and
amount of leakage (three levels). By multiplying these
two, an index value (1–12) is determined. This index
value is further categorized into a severity index with four
levels of UI: slight (1–2), moderate (3–6), severe (8–9)
and very severe (12) grade of UI. Typically slight inconti-
nence stands for leakage of drops a few times a month,
moderate incontinence daily leakage of drops, and severe
incontinence larger amounts at least once a week. The
severity index has been validated against a 48-hour "pad
weighing" test among 303 incontinent women. According
to this test, slight incontinence represented a mean leak-
age of 6 g/24 hours (95% CI 2–9), moderate incontinence
means a leakage of 17 g/24 hours (95% CI 13–22) and
severe incontinence a mean leakage of 56 g/24 hours
(95% CI 44–67). The severity index is thus a semi-objec-
tive and quantitative measure, and does not include the
woman's subjective perception of her leakage as being a
problem or not. The ISI has been translated and validated
by Spanish [13], Scottish [14] and American [15] groups
who demonstrated that its reliability and responsiveness
were also good. It has received the highest recommenda-
tion (grade A) from the 2nd and 3rd International Consul-
tation on Incontinence [16].
The second section of the third part contains five ques-
tions only for women who have, or have had, urinary
leakage. This section asks if there was any treatment or
help for UI and also a question for self-rating how disturb-
ing the urinary leakage is.
The last part of the questionnaire (consumption of drugs
and complementary medicine) asks the participant if she
used any kind of medicine the day before. A brief intro-
duction explains the meaning of "medicine" as any drugs
with or without prescription, in any form. If the answer is
positive, then a chart is available to answer what was the
medication, if it is a daily intake, and why she used it. The
answer could be a diagnosis, name of a disease, a symp-
tom or health effect. ATC (Anatomical Therapeutic Chem-Page 3 of 8
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and ICPC for coding the reason for using medication.
Recruitment, participants and representativeness
Among women born in 1953–1957 (N = 14,349) and
invited to take part in HUSK, 9,983 (71.8%) came to a
screening station. A total of 3,453 were selected by ran-
dom sampling to participate in the Cohort, and 2,331
(67.5%) of them met. After oral and written information,
2,230 (95.7%) consented to take part in the study.
Baseline demographic, social, and medical characteristics
of the Hordaland Women's Cohort (N = 2,230) compared
with the source population in HUSK (N = 7,746) are
shown in Table 2. The data shows that there are no signif-
icant differences between two groups except for education
and annual family income, which is higher among
women in the Cohort.
Table 3 compares urological characteristics between
women who are in the Cohort with the rest of the women
who answered the urological questionnaire. There were
no significant statistical differences between them, except
the fractions for urinary continence, distribution of type
of incontinence and amount of leakage.
Ethics and formal approvals
HUSK and the Cohort were both approved by the Norwe-
gian Data Inspectorate and Regional Committee for Med-
ical Research Ethics. The cohort approval includes the
right to obtain the full 11-digit personal identification
numbers which make it possible to merge files and also
extend the database with data from other sources, e.g. dif-
ferent national registers. All personnel and staff involved
in the survey are bound by an oath of confidentiality.
Discussion
We have been able to establish a cohort of more than
2,000 women for prospective studies of UI and related
Table 1: Topics covered in the questionnaires in the first six waves of the Cohort
Topics 1st wave 2nd wave 3rd wave 4th wave 5th wave 6th wave
Self-defined age x x x
Self-rated health x x x x x x
Doctor visit last 6 months x x x x x x
Physical activity x x x x x x
Mammography x x
Use of complementary medicine x x x
Pelvic floor exercises x x x x x x
Smoking x x x x x x
Hysterectomy x x
Oophorectomy x x
Weight x x x x x x
Enuresis x
Regular menstruation x x x x x x
Last menstruation x x x x x x
Menopause symptoms x x x x x x
Intensity of menopause symptoms x x x x x x
Hormone therapy x x x x x
Contraception x x x x x x
Who prescribed contraception x x x
Dysuria x x x x x x
Urinary frequency x x x x x x
Nocturia x x x x x x
Urinary retention symptoms x x x x x x
Urgency x x x x x
Stress UI x x x x x x
Urge UI x x x x x x
Other types of UI x x x x x x
UI frequency x x x x x x
UI amount x x x x x x
UI treatments x x x x x x
Bother of UI x x x x x x
Seeking medical help for UI x x x x x x
Drugs used yesterday x x x x x x
Name and reason for drug use x x x x x xPage 4 of 8
(page number not for citation purposes)
BMC Public Health 2008, 8:296 http://www.biomedcentral.com/1471-2458/8/296
Page 5 of 8
(page number not for citation purposes)
Table 2: Comparison of baseline socio-demographic characteristics between the Cohort and rest of the women in the Hordaland 
Health Study (HUSK).
HUSK minus the Cohort 
(N = 7746)
The Cohort 
(N = 2230)
P values
N % N %
Age at inclusion (years)
40 1465 18.9 481 21.6
41 1518 19.6 478 21.8
42 1578 20.4 456 20.4
43 1521 19.6 500 22.4
44 1664 21.5 315 14.1
Marital status 0.88
Not married 788 10.2 230 10.3
Married 5800 74.9 1676 75.2
Single 82 1.1 23 1.0
Divorced 861 2.7 248 2.4
Separated 212 2.7 53 2.4
Registered partnerships 3 0.03 0 0
Education 0.001
Elementary school 1616 20.7 408 18.2
The lower secondary 2687 34.7 749 33.6
The upper secondary 755 9.8 284 12.7
University less than 4 years 1371 17.7 410 18.4
University 4 years and more 1211 15.6 365 16.4
Missing 106 1.4 14 0.6
Annual family income, NOK 1000 0.018
0–199 1103 14.2 271 12.2
200–399 2483 32.1 702 31.5
> 400 2810 36.3 924 41.4
Missing 1350 17.4 333 14.9
Parity 0.768
0 544 7.0 166 7.4
1 731 9.4 211 9.5
2 2596 33.5 803 36.0
3+ 2802 36.1 794 35.6
Missing 1073 13.9 265 11.9
Body mass index (kg/m2) 0.328
Under-weight (< 18.5) 96 1.2 27 1.2
Normal (18.5–24.9) 4582 59.2 1357 60.9
Overweight (25–29.9) 2247 29.0 628 28.2
Obesity 797 10.4 216 9.6
Missing 24 0.3 2 0.1
Self-rated health 0.170
Bad 91 1.2 18 0.8
Not very good 1120 14.5 294 13.2
Good 4791 61.7 1407 63.1
Very good 1665 21.5 497 22.3
Missing 79 1.0 14 0.6
Lifestyle and medical conditions 0.199
Regular exercise 4519 58.4 1342 60.2 0.199
Daily smoking 2727 35.2 757 33.9 0.482
Asthma 503 6.5 155 7.0 0.444
Diabetes 87 1.1 23 1.0 0.715
Alcohol intake > 6 times/month 1417 18.3 418 18.8 0.095
Psychiatric problem/condition 1144 14.8 314 14.1 0.229
BMC Public Health 2008, 8:296 http://www.biomedcentral.com/1471-2458/8/296topics. The Cohort is planned to collect data every second
year for the 15-year period between 1997–2012. The
Cohort is population-based, with minimal selection bias.
This Cohort is thus a rather unique study in comparison
to many other projects with similar purposes.
The Cohort represents a relatively large random sample of
about 15% of the total population of women born
between 1953–57 in the county of Hordaland, which
increases the generalization of our findings. The source
study had a high participation rate, and of those who were
invited to participate in the Cohort, almost all agreed to
take part
The main objectives are to analyze incidence, remission,
or development patterns in severity and types of UI. The
variables and questions are adapted to current ICS defini-
tions and the questionnaire contains many validated
questions and indices from previous studies. The inconti-
nence case definition is in accordance with the new defi-
nition of the ICS [18]. Furthermore, the UI data set is in
accordance with the recommendations from the 3rd ICI
Table 3: Comparison of urological characteristics between the Cohort and the rest of the women in the Hordaland Health Study 
(HUSK)
HUSK minus the Cohort 
(N = 3400)
The Cohort 
(N = 1920)
P value
N % N %
Dysuria episodes last 12 months 0.763
No 2761 81.2 1541 80.3
1–2 times 399 11.7 232 12.3
3–5 times 102 3.0 61 3.2
> 5 times 82 2.4 54 2.8
Missing 56 1.6 32 1.7
Nocturia 0.159
None 2445 71.9 1417 73.8
1 time 767 22.6 405 21.1
2 times 94 2.8 56 2.9
> 2 times 43 1.3 14 0.7
Missing 51 1.5 28 1.5
Feeling of incomplete emptying 274 8.1 152 7.9 0.742
Any urinary incontinence 844 24.8 554 28.9 0.040
Frequency of incontinence 0.070
< 1/month 252 29.9 204 36.8
> 1/month 305 36.1 187 33.8
> 1/week 186 22.0 105 19.0
Everyday 61 7.2 38 6.9
Missing 40 4.7 20 3.6
Amount of leakage, distribution 0.0149
Drops 509 60.3 360 65.0
Small amounts 291 34.5 163 29.4
Large amounts 15 1.8 10 1.8
Missing 29 3.4 21 3.8
Incontinence Severity Index 0.107
Slight (1–2) 447 53.0 325 61.4
Moderate (3–6) 305 36.2 177 31.9
Severe/very severe (8–9 & 12) 44 5.2 27 4.9
Missing 48 5.7 25 2.0
Incontinence type distribution
Stress incontinence 437 51.8 307 55.4
Urge incontinence 68 8.1 61 11.0
Mixed incontinence 268 31.8 146 26.4
Could not be classified 71 8.4 40 7.2
Duration of urinary incontinence 0.875
0–5 years 536 63.5 352 63.5
5–10 years 171 20.3 111 20.0
> 10 years 86 10.2 52 9.4
Missing 51 6.0 39 7.0Page 6 of 8
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comprehensive data set for further analyses. At baseline,
the Cohort had a prevalence of 28.9% for UI. The majority
of women have slight degree of UI, which is more seldom
than once a week and with small amounts. And more than
half of women had stress incontinence. Our data shows
that the cohort population is very similar to the source
population, and the UI data also similar to previous find-
ings from Norway [4]. As most women had slight degree
of UI, they will possibly not seek clinical help. In the
Cohort, UI is determined based on simple self diagnosis
by women [12] and this reduces bias of the real prevalence
of UI.
There are some possible limitations to the study. The age
span of 40–44 years at the start is rather narrow and
makes the Cohort exclusive for middle-age women. How-
ever, this was done on purpose, for concentrating the
analyses for the peri- and postmenopausal decade.
Although including more than 2,000 women, the statisti-
cal power may be a problem due to small sample size for
some subgroups and sub-analyses.
Many cross-sectional studies have investigated continence
status and associated risk factors. But there are not many
cohort studies for UI, especially in middle-age women,
and many previous studies are limited in duration and
number of intervals [2]. Many have focused on specific
subjects like pregnancy, diseases or other subgroups of
women. Most cohort studies on UI in healthy middle-
aged women are short and have not more than two waves
[3,4,6,19-25].
Our data shows that the cohort population is very similar
to the source population, and the UI data also similar to
previous findings from Norway. Thus the external and
internal validity of the study is expected to be good. This
cohort study is therefore a potentially good tool for pro-
spective analyses of incidence, remission and develop-
ment of UI, including type and severity considerations,
and associated risk factors.
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